While the likes of London, Hong Kong and New York typically dominate the FDI tables, smaller cities find that they can punch above their weight by putting the focus on innovation and technology. Karen E Thuermer looks at how Fredericton, Lafayette, Heredia, Ghent, Eindhoven and Grenoble do it.
Our latest View From series coverage
Date: June 15 - 18, 2015
Location: Philadelphia, USA
About 15,000 of biotech and pharmaceutical players from 65 countries are attending the 2015 BIO International Convention. fDi Magazine's deputy editor, Michal Kaczmarski, is reporting on the main topics of discussion and interview FDI and industry professionals.
View From BIO is your hub for the 2015 BIO International Convention, bringing you the latest coverage, FDI data and articles from the biotechnology industry.
Register here to receive daily updates from BIO 2015 and sign up to the fDi Intelligence e-newsletter.
On the right you will also find our View From series coverage of previous events.
Latest coverage from BIO 2015
Day 4
- Interview with Sandra de Wild, sector specialist, Life Sciences & Health at Netherlands Foreign Investment Agency - View From BIO 2015
- Interview with Tracey Maconachie, president, Life Science Association of Manitoba - View From BIO 2015
- Interview with Ken Poonoosamy, managing director, Board of Investment of Mauritius - View From BIO 2015
- Interview with Hidetaka Nishimura, director, Bio-Industry Division of Ministry of Economy, Trade and Industry of Japan - View From BIO 2015
Day 3
- Interview with Joana Branco, innovation manager, Biocant - Technology Transfer Association, Portugal - View From BIO 2015
- Interview with Cristina Oyon, strategic initiatives manager, Basque Business Development Agency - View From BIO 2015
- Interview with James Kimotho, head of production department, Kenya Medical Research Institute - View From BIO 2015
Day 2
- Interview with Ajarin Pattanapanchai, deputy secretary general, Thailand Investment Board - View From BIO 2015
- Interview with Matthew Hudes, Biopharma segment leader at Deloitte - View From BIO 2015
- Interview with Sevim Tekeli, project coordinator, Instanbul Health Industry Cluster - View From BIO 2015
- Interview with Prof. Karniyus Gamaniel, CEO, National Institute for Pharmaceutical R&D, Nigeria - View From BIO 2015
Day 1
BIO 2015 Preview
Biotechnology and pharmaceuticals FDI data
Between March 2010 and March 2015 a total of 1,395 FDI projects were recorded in the biotechnology and pharmaceuticals sectors. These projects represent a total capital investment of $52.92bn which is an average investment of $37.90m per project. During the period, a total of 130,532 jobs were created.
Trends spotted using fDi Markets, an online database tracking crossborder greenfield investment, covering all sectors and countries worldwide. Contact us for more information.
Related Articles
View from Europe: big pharma's big impact
Big pharma is big business in Europe, with initiatives such as the UK's Med City demonstrating why the region is the sector's number one trader.
View from Asia: a bigger, better pharmaceutical industry
Asia's pharmaceutical industry is growing at a rapid pace, with demand among its population increasing too.
Thailand's new lease of life
Thailand's expertise in the life sciences sector has long remained under the radar, with a lack of investment preventing many of the discoveries from its scientific community making it to the commercial stage. But a government entity, the Thailand Centre for Excellence for Life Sciences, is looking to change this.
Biotech-pharma hotspots on the up
Locations are taking advantage of the growing demand for healthcare, bringing together academia, big industry, start-ups, hospitals and sources of capital to create thriving specialised biomedical-pharmaceutical clusters.
View From Series archive
International meetings
2018
2017
2016
2015
2014
2013
2012
2011